Murchinson Ltd. Oramed Pharmaceuticals Inc. Transaction History
Murchinson Ltd.
- $818 Million
- Q1 2025
A detailed history of Murchinson Ltd. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Murchinson Ltd. holds 1,751,759 shares of ORMP stock, worth $3.66 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,751,759
Previous 1,750,959
0.05%
Holding current value
$3.66 Million
Previous $4.24 Million
11.54%
% of portfolio
0.46%
Previous 2.03%
Shares
7 transactions
Others Institutions Holding ORMP
# of Institutions
60Shares Held
8.05MCall Options Held
11.2KPut Options Held
200-
Bml Capital Management, LLC Zionsville, IN3.08MShares$6.44 Million5.25% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.77 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$765,7782.07% of portfolio
-
Rathbones Group PLC Liverpool, X0233KShares$487,0070.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny213KShares$445,1690.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $81.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...